Our results show that strategically targeting TIM3, LAG3, TIGIT, CTLA4, IFITM, TREM2 and PD-1 in MMRd and also MMRp CRC tumors not only further limits tumor growth but can also significantly increase the complete elimination of tumors. The gene discussed is CTLA4; the disease is neoplasm.